Cargando…

Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)–Medicare investigation of treatment patterns and overall survival

INTRODUCTION: Mesothelioma is a rare malignancy typically associated with exposure to asbestos and poor survival. The purpose of this investigation was to describe mesothelioma patient characteristics, treatment patterns, and overall survival (OS) utilizing the National Cancer Institute’s Surveillan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beebe-Dimmer, Jennifer L, Fryzek, Jon P, Yee, Cecilia L, Dalvi, Tapashi B, Garabrant, David H, Schwartz, Ann G, Gadgeel, Shirish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087771/ https://www.ncbi.nlm.nih.gov/pubmed/27822122 http://dx.doi.org/10.2147/CLEP.S105396

Ejemplares similares

The epidemiology of malignant giant cell tumors of bone: an analysis of data from the Surveillance, Epidemiology and End Results Program (1975–2004)
por: Beebe-Dimmer, Jennifer L, et al.
Publicado: (2009)

Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database
por: Beebe-Dimmer, Jennifer L., et al.
Publicado: (2018)

Correction to: Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database
por: Beebe-Dimmer, Jennifer L., et al.
Publicado: (2018)

Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER‐Medicare investigation
por: Beebe‐Dimmer, Jennifer L., et al.
Publicado: (2019)

Estimates of Overall Survival in Patients With Cancer Receiving Different Treatment Regimens: Emulating Hypothetical Target Trials in the Surveillance, Epidemiology, and End Results (SEER)–Medicare Linked Database
por: Petito, Lucia C., et al.
Publicado: (2020)

Hemochromatosis, Iron Overload–Related Diseases, and Pancreatic Cancer Risk in the Surveillance, Epidemiology, and End Results (SEER)-Medicare
por: Julián-Serrano, Sachelly, et al.
Publicado: (2021)

Disparities in cancer-specific and overall survival in black women with endometrial cancer: A Medicare-SEER study
por: Saris, Daniel H., et al.
Publicado: (2022)

Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients
por: Taioli, Emanuela, et al.
Publicado: (2015)

Comparison of SEER Treatment Data With Medicare Claims
por: Noone, Anne-Michelle, et al.
Publicado: (2016)

Nomograms for predicting the overall survival of patients with cerebellar glioma: an analysis of the surveillance epidemiology and end results (SEER) database
por: Li, Jie, et al.
Publicado: (2021)

Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: a Surveillance Epidemiology and End Results (SEER) population analysis
por: Thumma, Sudheer R, et al.
Publicado: (2012)

Treatment patterns and outcomes in older patients with advanced malignant pleural mesothelioma: Analyses of Surveillance, Epidemiology, and End Results‐Medicare data
por: Danese, Mark D., et al.
Publicado: (2021)

Post-treatment surveillance testing of patients with colorectal cancer and the association with survival: protocol for a retrospective cohort study of the Surveillance, Epidemiology, and End Results (SEER)-Medicare database
por: Hines, Robert B, et al.
Publicado: (2018)

Longevity and pleural mesothelioma: age-period-cohort analysis of incidence data from the Surveillance, Epidemiology, and End Results (SEER) Program, 1973–2013
por: Kerger, Brent D.
Publicado: (2018)

Influence of marital status on overall survival in patients with ovarian serous carcinoma: finding from the surveillance epidemiology and end results (SEER) database
por: Luo, Pei, et al.
Publicado: (2019)

Prediction of overall survival of non-small cell lung cancer with bone metastasis: an analysis of the Surveillance, Epidemiology and End Results (SEER) database
por: Shi, Si, et al.
Publicado: (2021)

Overview of the SEER—Medicare Health Outcomes Survey Linked Dataset
por: Ambs, Anita, et al.
Publicado: (2008)

Stage II/III Rectal Cancer Post-Treatment Surveillance Patterns of Care: A SEER- Medicare Study
por: Chioreso, Catherine, et al.
Publicado: (2021)

Hepatocellular Carcinoma Survival by Etiology: A SEER‐Medicare Database Analysis
por: Brar, Gagandeep, et al.
Publicado: (2020)

3014 Identification of a Cohort to Study Treatment Patterns in Elderly Patients with Incident Hodgkin Lymphoma (HL) using Surveillance, Epidemiology and End Results (SEER)-Medicare Data
por: Rodday, Angie Mae, et al.
Publicado: (2019)

Trends in Sociodemographic Disparities in Colorectal Cancer Staging and Survival: A SEER–Medicare Analysis
por: Liang, Peter S., et al.
Publicado: (2020)

Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database
por: Lei, Lei, et al.
Publicado: (2021)

Opportunities for Personalizing Colorectal Cancer Care: An Analysis of SEER-Medicare Data
por: Rivers, Zachary T., et al.
Publicado: (2022)

67409 Quantifying Unmeasured Confounding in Relationship between Treatment Intensity and Outcomes among Older Patients with Hodgkin Lymphoma (HL) using Surveillance, Epidemiology and End Results (SEER)-Medicare Data
por: Rodday, Angie Mae, et al.
Publicado: (2021)

Prognostic Factors of Adrenocortical Carcinoma: An Analysis of the Surveillance Epidemiology and End Results (SEER) Database
por: Wang, Sen, et al.
Publicado: (2017)

Carcinosarcoma of the Uterus: A Study From the Surveillance Epidemiology and End Result (SEER) Database
por: Nama, Noor, et al.
Publicado: (2020)

Trends in Gynecologic Carcinosarcoma Based on Analysis of the Surveillance Epidemiology End Result (SEER) Database
por: Lee, Joo Won, et al.
Publicado: (2023)

How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology
por: Che, Wen-Qiang, et al.
Publicado: (2023)

Medicare Cost at End of Life
por: Duncan, Ian, et al.
Publicado: (2019)

Evaluation of health behaviors and overall quality of life in younger adult African American cancer survivors
por: Trendowski, Matthew R., et al.
Publicado: (2022)

4074 The Role of Immortal Time Bias When Linking Treatment to Outcomes among Older Patients with Incident Hodgkin Lymphoma (HL) using Surveillance, Epidemiology and End Results (SEER)-Medicare Data
por: Rodday, Angie Mae, et al.
Publicado: (2020)

Medicare reimbursement and regression to the mean
por: Beebe, James C.
Publicado: (1988)

Racial Disparities in Breast Cancer Treatments and Adverse Events in the SEER-Medicare Data
por: Wieder, Robert, et al.
Publicado: (2023)

Marital Status and Survival in Osteosarcoma Patients: An Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database
por: Qiu, Shui, et al.
Publicado: (2019)

Treatment method and prognostic factors of chondrosarcoma: based on Surveillance, Epidemiology, and End Results (SEER) database
por: Hua, Kun-Chi, et al.
Publicado: (2020)

Prognostic Factors in Gastrointestinal Leiomyosarcomas: An Analysis Using the Surveillance, Epidemiology, and End Results (SEER) Database
por: Senapathi, Harshavardhan, et al.
Publicado: (2021)

Using Pointwise Mutual Information for Breast Cancer Health Disparities Research With SEER-Medicare Claims
por: Egleston, Brian L., et al.
Publicado: (2023)

PD-L1 expression, EGFR and KRAS mutations and survival among stage III unresected non-small cell lung cancer patients: a Danish cohort study
por: Cronin-Fenton, Deirdre, et al.
Publicado: (2021)

Historical cancer incidence and mortality assessment in an Illinois community proximal to a former manufactured gas plant
por: Alexander, Dominik D, et al.
Publicado: (2014)

Combination pembrolizumab plus chemotherapy: a new standard of care for patients with advanced non-small-cell lung cancer
por: Weinberg, Frank, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_knh6i35mvop1sk85g5rjsf021o